Implantica AG (IPLTF)

Market Cap	1.26B +34.6%
Revenue (ttm)	2.43M +7.1%
Net Income	-23.04M
EPS	-0.08
Shares Out	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,000
Average Volume	558
Open	4.660
Previous Close	4.830
Day's Range	4.660 - 4.660
52-Week Range	4.660 - 6.080
Beta	n/a
RSI	n/a
Earnings Date	May 8, 2026

About Implantica AG

Implantica AG engages in the research and distribution of medical implants in Switzerland. The company’s lead product candidate is RefluxStop, a passive CE-marked implant for prevention of gastroesophageal reflux disease. It focuses on two treatment areas, Gastrointestinal surgery and Urology. It is also involved in the development of eHealth platform, a digital health system to support its pipeline of smart medical implants designed for a safe and secure control and monitoring over the internet; e-InVivo, a sensor implants to monitor a multitu...

• Industry: Surgical and Medical Instruments and Apparatus
• Founded: 2015
• Employees: 50
• Stock Exchange: OTCMKTS
• Ticker Symbol: IPLTF

Financial Performance

In 2025, Implantica AG's revenue was 2.07 million, an increase of 7.08% compared to the previous year's 1.94 million. Losses were -19.63 million, -15.89% less than in 2024.

Financial numbers in EUR